Opinion

Facebook chatbot wasn’t a total disaster

As one of the 21st Century’s most powerful data brokers, Facebook is best known for its role in sucking up the personal information of billions of users for its advertising clients. That lucrative model has led to ever-heightening risks — Facebook recently shared private messages between a Nebraska mother and her teenage daughter with police investigating the girl’s at-home abortion. ...

Read More »

PBOC surprise suggests China’s outlook is dire

  China’s faltering economy requires a lifeline from the central bank, regardless of admonitions that inflation is creeping higher and needs to be contained. With growth struggling and demand for credit cratering, the People’s Bank of China (PBOC) has made clear that it’s the recovery first. Price increases might be worrying, but are a second order problem — for now. ...

Read More »

Should Fed resist opting for quick and easy again?

  Over the last 18 months or so, the quick and easy interpretation of inflation data has turned out to be incorrect. Will it be different going forward? Markets sure hope so. Federal Reserve officials seem more cautious, and rightly so. The markets’ latest narrative pivot is not the right one for the world’s most powerful central bank. When the ...

Read More »

Over New York, London and Hong Kong? Time to move on

The financial capitals of the world have lost their luster. The bright lights of New York City seem to have dimmed. London has far too many issues to contend with, from inflation, messy politics and homes not built for the heat to a dysfunctional international airport. Hong Kong is a dark shadow of what it once was: A former British ...

Read More »

Driverless trucks can be safe, efficient

Long-haul trucking has always been a tough job that keeps drivers away from their families for days and sometimes weeks. It’s no wonder there’s a perennial shortage of them. The pool of available drivers is aging — the median age is about 46 and climbing — and the industry is struggling to attract younger people to get behind the wheel ...

Read More »

Please! don’t ban Chinese investment in US farmland

  What happens to America’s food supply if foreigners, and not American farmers, own the amber waves of grain? It’s an old fear that’s generating new tensions, thanks to a Chinese company’s acquisition of 300 acres of North Dakota farmland . The company plans to build a corn milling operation. Opponents fear that it will also build the capacity to ...

Read More »

US Senate’s new tax legislation has issues

  The Inflation Reduction Act, passed by the Senate and now headed to the House, is a notable achievement. It provides much-needed incentives for investment in clean energy and takes long-overdue steps to control drug prices. Its new revenue will more than pay for the extra spending, so that over the course of 10 years the plan will trim public ...

Read More »

Bank of England takes a $100b leap into unknown

Central banks are about to start withdrawing the stimulus they’ve pumped into their economies by buying bonds. For the Bank of England (BOE) in particular, reducing its balance sheet while simultaneously raising interest rates takes monetary policy into uncharted territory. Policy makers could quickly find themselves in the crosshairs, blamed for exacerbating the economic slowdown they’ve forecast. The UK central ...

Read More »

Singapore’s next big challenge is here

To listen to Singapore’s leader, the Bank of England nailed it. The UK central bank’s warning of a tough new era that sent shockwaves through the world of monetary economics resonated in the city-state. The tiny republic that’s staked its survival on the ebbs and flows of global capitalism is girding for a protracted period of slacker growth and a ...

Read More »

GSK’s got heartburn that £50b could probably fix

  Investors are waking up to the risk of litigation against the makers of Zantac, once a blockbuster treatment for heartburn. All of a sudden, GSK Plc’s decision to spin off rather than sell its consumer-healthcare business, Haleon Plc, is looking costly. Haleon, which is behind brands like Sensodyne toothpaste and Panadol painkillers, was a joint venture between GSK, the ...

Read More »
Send this to a friend